5th AGM results: both resolutions passed with 100% approval

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹162.20

prior close

₹164.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+3.3% vs market

Pharmaceuticals peers, median of 172sector-1.5%+3.2% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 3.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7-1.6+3.3-1.5+3.2

Next day

-2.6-0.6-2.0-1.0-1.6

-2.6-0.8-1.7-1.9-0.7

-3.5-2.1-1.4-2.4-1.1

—-2.1—-3.3—

+6.1-0.8+7.0-2.4+8.5

+17.1-3.8+20.9-4.3+21.4

15d

-3.0-6.9+3.9-7.9+4.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Speciality Medicines Limited held its 5th AGM on September 28, 2026 via video conferencing. Two ordinary resolutions passed with 100% approval: adoption of audited financial statements for FY ended March 31, 2026, and re-appointment of Mr. Sumit Goyani as director (retiring by rotation). 5,534,760 votes polled in favor (about 63 percent of outstanding), zero against. 13 of 410 shareholders attended via video call.

Likely market impact

Routine AGM business. Both resolutions passed unanimously with zero dissent. Minimal stock impact expected as audited results adopted and director re-appointed.